88 related articles for article (PubMed ID: 24273276)
1. [Effect of MHSP65-TCL anti-melanoma vaccine on the activity of immunocytes].
Dong B; Dai G; Qi Z; Yang G; Lu J; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1673-7. PubMed ID: 24273276
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice.
Dong B; Sun L; Wu X; Zhang P; Wang L; Wei H; Zhou L; Hu X; Yu Y; Hua S; Wang L
Cancer Immunol Immunother; 2010 Jun; 59(6):899-908. PubMed ID: 20087582
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice.
Dong B; Dai G; Ding Y; Wang B; Zhang S
Int Immunopharmacol; 2018 Feb; 55():306-311. PubMed ID: 29310106
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of mHSP65-TTL enhanced by administration of low dose cyclophosphamide in pancreatic cancer-bearing mice.
Xuan W; Yan Y; Wan M; Wu X; Ji D; Wang L; Lin C; Chen Y; Yu Y; Zhang X
Int Immunopharmacol; 2015 Jul; 27(1):95-103. PubMed ID: 25907246
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
6. Detection of RACK1 and CTNNBL1‑induced activation of mouse splenocytes using an immunoprecipitation‑based technique.
Dong B; Dai G; Xu L; Shi D
Mol Med Rep; 2017 Nov; 16(5):7056-7063. PubMed ID: 28901482
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharide from
Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
9. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with B16 tumor cell lysate plus recombinant Mycobacterium tuberculosis Hsp70 induces antimelanoma effect in mice.
Li H; Yu Y; Sun L; Wang H; Zhang P; Wei H; Wang L; Wan M; Cao Z; Wang Y; Chen Y; Dong B; Wang L
Cancer Biother Radiopharm; 2010 Apr; 25(2):185-91. PubMed ID: 20423232
[TBL] [Abstract][Full Text] [Related]
11. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
[TBL] [Abstract][Full Text] [Related]
12. B16 cell lysates plus polyinosinic-cytidylic acid effectively eradicate melanoma in a mouse model by acting as a prophylactic vaccine.
Lin B; Zhao H; Fan J; Xie F; Wang W; Ding X
Mol Med Rep; 2014 Aug; 10(2):911-6. PubMed ID: 24840631
[TBL] [Abstract][Full Text] [Related]
13. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Björkdahl O; Dohlsten M; Sjögren HO
Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
[TBL] [Abstract][Full Text] [Related]
15. Generation of a prophylactic melanoma vaccine using whole recombinant yeast expressing MART-1.
Riemann H; Takao J; Shellman YG; Hines WA; Edwards CK; Franzusoff A; Norris DA; Fujita M
Exp Dermatol; 2007 Oct; 16(10):814-22. PubMed ID: 17845213
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tumor effect of cisplatin combined with DC vaccine on tumor-bearing mice].
You HY; Lian WG; Zhang HL; Wang JX; Zhang KX; Song SX
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):336-40. PubMed ID: 22883452
[TBL] [Abstract][Full Text] [Related]
17. Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax.
Mansour M; Pohajdak B; Kast WM; Fuentes-Ortega A; Korets-Smith E; Weir GM; Brown RG; Daftarian P
J Transl Med; 2007 Apr; 5():20. PubMed ID: 17451606
[TBL] [Abstract][Full Text] [Related]
18. [Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism].
Wang J; Zhou ZD; Xia DJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):60-4. PubMed ID: 17302067
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis.
Kumar Chauhan S; Kumar Tripathy N; Sinha N; Singh M; Nityanand S
Clin Exp Immunol; 2004 Dec; 138(3):547-53. PubMed ID: 15544635
[TBL] [Abstract][Full Text] [Related]
20. Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes.
Sun LX; Lin ZB; Li XJ; Li M; Lu J; Duan XS; Ge ZH; Song YX; Xing EH; Li WD
Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):149-54. PubMed ID: 20964805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]